These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10399833)

  • 21. Development and Optimization of Orally and Topically Applied Liquid Crystal Drug Formulations.
    Kadhum WR; Hada T; Hijikuro I; Todo H; Sugibayashi K
    J Oleo Sci; 2017; 66(9):939-950. PubMed ID: 28867759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of molecular weight on the dermatopharmacokinetics and systemic disposition of drugs after intracutaneous injection.
    Yoshida D; Todo H; Hasegawa T; Sugibayashi K
    Eur J Pharm Sci; 2008 Sep; 35(1-2):5-11. PubMed ID: 18635344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects.
    Benfeldt E
    Acta Derm Venereol Suppl (Stockh); 1999; 206():1-59. PubMed ID: 10605601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transdermal permeation of drugs with differing lipophilicity: Effect of penetration enhancer camphor.
    Xie F; Chai JK; Hu Q; Yu YH; Ma L; Liu LY; Zhang XL; Li BL; Zhang DH
    Int J Pharm; 2016 Jun; 507(1-2):90-101. PubMed ID: 27154251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of a Topically Applied Gel Spray Formulation with Ivermectin Using a Novel Low Molecular Weight Gelling Agent, Palmitoyl-Glycine-Histidine, to Treat Scabies.
    Dahlizar S; Futaki M; Okada A; Kadhum WR; Todo H; Sugibayashi K
    Chem Pharm Bull (Tokyo); 2018; 66(3):327-333. PubMed ID: 29491265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex vivo transdermal absorption of a liposome formulation of diclofenac.
    Sacha M; Faucon L; Hamon E; Ly I; Haltner-Ukomadu E
    Biomed Pharmacother; 2019 Mar; 111():785-790. PubMed ID: 30612003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery.
    Förster M; Bolzinger MA; Fessi H; Briançon S
    Eur J Dermatol; 2009; 19(4):309-23. PubMed ID: 19443302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of epidermal turnover on the dynamics of percutaneous drug absorption.
    Simon L; Kim KS; Kanneganti K
    Math Biosci; 2011 Jan; 229(1):16-21. PubMed ID: 21040736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous absorption of physiologically active peptides, ebiratide and elcatonin, in rats.
    Ogiso T; Paku T; Iwaki M; Tanino T; Nishioka S
    Biol Pharm Bull; 1994 Aug; 17(8):1094-100. PubMed ID: 7820115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A rabbit ear flap perfusion experiment to evaluate the percutaneous absorption of drugs.
    Seki T; Hosoya O; Yamazaki T; Sato T; Saso Y; Juni K; Morimoto K
    Int J Pharm; 2004 May; 276(1-2):29-40. PubMed ID: 15113611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of an artificial skin model to study transdermal absorption of drugs in inflamed skin.
    Oshima S; Suzuki C; Yajima R; Egawa Y; Hosoya O; Juni K; Seki T
    Biol Pharm Bull; 2012; 35(2):203-9. PubMed ID: 22293350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical penetration of piroxicam is dependent on the distribution of the local cutaneous vasculature.
    Monteiro-Riviere NA; Inman AO; Riviere JE; McNeill SC; Francoeur ML
    Pharm Res; 1993 Sep; 10(9):1326-31. PubMed ID: 8234171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of particle size on skin permeation and retention of piroxicam in aqueous suspension.
    Moribe K; Shibata M; Furuishi T; Higashi K; Tomono K; Yamamoto K
    Chem Pharm Bull (Tokyo); 2010 Aug; 58(8):1096-9. PubMed ID: 20686267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of 1-O-ethyl-3-butylcyclohexanol on the skin permeation of drugs with different physicochemical characteristics.
    Li CJ; Obata Y; Higashiyama K; Nagai T; Takayama K
    Int J Pharm; 2003 Jun; 259(1-2):193-8. PubMed ID: 12787647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An alternative lidocaine hydrochloride liposomal gel formulation: preparation, percutaneous permeation, and release kinetics.
    Gong JH; Liu Y; Tang LH; Xu XJ; Zhang XN
    PDA J Pharm Sci Technol; 2006; 60(4):259-63. PubMed ID: 17089695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of β-blocker gel and effect of dosing volume for topical delivery.
    Zhang Q; Chantasart D; Li SK
    J Pharm Sci; 2015 May; 104(5):1721-31. PubMed ID: 25694227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of percutaneous absorption of 4-nerolidylcathecol from four topical formulations.
    Röpke CD; Kaneko TM; Rodrigues RM; da Silva VV; Barros S; Sawada TC; Kato MJ; Barros SB
    Int J Pharm; 2002 Dec; 249(1-2):109-16. PubMed ID: 12433439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
    Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
    Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
    Padamwar MN; Pokharkar VB
    Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of formulation variables on the percutaneous permeation of ketoprofen from gel formulations.
    El-Kattan AF; Asbill CS; Kim N; Michniak BB
    Drug Deliv; 2000; 7(3):147-53. PubMed ID: 10989915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.